Industrial technology company Fortive (NYSE: FTV) announced better-than-expected revenue in Q2 CY2026, with sales up 7.9% year on year to $1.10 billion. Its non-GAAP profit of $0.74 per share was 4.9% above analysts’ consensus estimates.

Is now the time to buy FTV? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Fortive’s second quarter saw key operational achievements, but the market responded negatively, with shares declining significantly after results. Management highlighted robust organic growth, especially from new product introductions at Fluke and expanded AI-enabled offerings across software brands. CEO Olumide Soroye emphasized that “our accelerating innovation velocity again translated into faster growth,” noting strong recurring revenue performance and progress in high-growth verticals such as data centers and healthcare. Despite these gains, product mix and regional headwinds, particularly in EMEA, weighed on margins.

Looking ahead, Fortive’s updated guidance is shaped by continued investment in innovation, expansion in strategic end markets, and ongoing capital deployment through bolt-on acquisitions. Management is counting on commercial momentum in North America, enhanced AI-driven product features, and increased recurring revenue streams to sustain growth. CFO Mark Okerstrom cautioned that margin trends will be affected by product mix shifts and strategic investments, but expects annual EBITDA margin expansion within the company’s targeted range. The company believes its disciplined capital allocation and focus on operational execution will position it for sustained profitability.

Key Insights from Management’s Remarks

Management attributed performance to accelerated innovation, regional growth in APAC and Latin America, and recurring revenue strength. Investment in both organic initiatives and targeted M&A also impacted results.

• New products drive growth: Fluke’s new offerings, including CertiFiber Max, addressed demand in data centers and defense, helping pull through broader portfolio sales. Management described new product contributions as critical to 6.7% core revenue growth.
• AI-enabled software expansion: Fortive’s software brands saw strong adoption of recently launched AI capabilities, such as predictive maintenance in eMaint and Flash AI at Gordian, which management said cut customer project timelines and supported higher contract win rates.
• Recurring revenue momentum: Recurring service and consumables revenue increased across segments, notably in Fluke’s services and ASP’s consumables. CEO Soroye noted double-digit recurring revenue growth at Fluke, reflecting a shift toward lifecycle engagement.
• Geographic diversification: While North America remained the strongest region, management saw sequential acceleration in APAC and Latin America. EMEA faced headwinds from economic and geopolitical factors but did not offset overall growth.
• Bolt-on acquisition and capital returns: The acquisition of a majority stake in UV Smart expanded ASP’s healthcare portfolio, and $200 million in share repurchases were executed. Management indicated future M&A will focus on core hardware brands and complementary software with network effects.

Drivers of Future Performance

Fortive’s outlook centers on continued innovation, recurring revenue expansion, and disciplined capital allocation, with margin expansion tempered by product mix and investment priorities.

• Strategic innovation focus: Management expects new product launches and AI enhancements to drive demand in high-growth sectors such as data centers, healthcare, and facility lifecycle management. These initiatives are designed to support both top-line growth and pricing power.
• Regional and segment momentum: Ongoing investments in North America, APAC, and Latin America are intended to capture market share, while management sees hospital capital spending and healthcare procedure volumes recovering, supporting Advanced Healthcare Solutions segment growth.
• Margin and cost management: CFO Okerstrom indicated that while annual EBITDA margin expansion is targeted within the 50- to 100-basis-point range, quarterly margins may fluctuate due to product mix dynamics, increased investment in growth initiatives, and normal seasonal patterns.

Catalysts in Upcoming Quarters

In upcoming quarters, the StockStory team will be monitoring (1) the pace of adoption and revenue contribution from new AI-enabled software features across key brands, (2) stabilization and potential growth in healthcare capital equipment sales as hospital budgets recover, and (3) execution of targeted bolt-on acquisitions to strengthen core hardware and software platforms. Progress on recurring revenue initiatives and successful integration of recent acquisitions will also be important indicators of execution.

Fortive currently trades at $60.33, down from $64.09 just before the earnings. At this price, is it a buy or sell? Find out in our full research report (it’s free).

Now Could Be The Perfect Time To Invest In These Stocks

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.